Big Move For NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc. (NRXP:NASDAQ) shot up at $3.01, representing a gain of 17.6%. On Fri, Feb 11, 2022, NRXP:NASDAQ touched a New 2-Week Low of $2.56. The stock appeared on our News Catalysts scanner on Fri, Feb 11, 2022 at 08:16 AM in the 'BIOTECH' category. From Mon, Jan 31, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Mon, Nov 29, 2021 at $10.39 with a volume of 74M+.
About NRX Pharmaceuticals Inc. (NRXP:NASDAQ)
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening...
Top 10 Gainers:
- BioDelivery Sciences International, Inc. (BDSI:NASDAQ), 52.75%
- Knightscope Inc. (KSCP:NASDAQ), 32.91%
- China Online Education Group (COE:NYSE), 27.67%
- Cornerstone Building Brands, Inc. (CNR:NYSE), 21.96%
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 17.58%
- Team, Inc. (TISI:NYSE), 16.63%
- Astrea Acquisition Corp. (ASAX:NASDAQ), 16.49%
- Cadiz Inc. (CDZI:NASDAQ), 15.79%
- Battalion Oil Corporation (BATL:NYSEMKT), 14.94%
- Dingdong (Cayman) Limited American Depositary Shares (each two representing three) (DDL:NYSE), 14.13%